NCT06168799 - Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery | Biotech Hunter

Enrollment

271

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

October 5, 2025

Study Completion Date

November 30, 2025

Conditions

Open Heart Surgery

Interventions

DRUG

Ilofotase alfa

After dilution of the concentrate, the investigational medicinal product will be administered by intravenous infusion for 1 hour at the same day before and after the surgery (Day 1)

DRUG

Placebo

After dilution of the concentrate, the investigational medicinal product will be administered by intravenous infusion for 1 hour at the same day before and after the surgery (Day 1)

Trial Locations (1)

Unknown

Research site, Munich